Tolerability of the COX-1/COX-2 inhibitor lornoxicam in the treatment of acute and rheumatic pain
Author:
Affiliation:
1. Central University of Venezuela, Caracas, Venezuela
2. Takeda Pharmaceuticals International GmbH, Zurich, Switzerland
3. IM Sechenov First Moscow State Medical University, Moscow, Russia
Abstract
Publisher
Future Medicine Ltd
Subject
General Medicine
Link
https://www.futuremedicine.com/doi/pdf/10.2217/pmt.16.7
Reference36 articles.
1. Gastrointestinal Safety of Cyclooxygenase-2 Inhibitors: A Cochrane Collaboration Systematic Review
2. Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials
3. Cardiovascular Risk and Inhibition of Cyclooxygenase
4. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
5. Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Calcium complexes of oxicams: new dimensions in rheumatoid arthritis treatment;Future Medicinal Chemistry;2022-12
2. Lornoxicam in the treatment of acute and chronic musculoskeletal pain;Modern Rheumatology Journal;2022-08-23
3. Lornoxicam-Loaded Chitosan-Decorated Nanoemulsion: Preparation and In Vitro Evaluation for Enhanced Transdermal Delivery;Polymers;2022-05-09
4. Possibilities of individual choice of NSAIDs on the example of the oxicam class, taking into account clinical and pharmacological characteristics;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2022
5. Presumptive Lornoxicam Intoxication in Four Dogs;Topics in Companion Animal Medicine;2021-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3